|
C20ORF20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.664300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.177220E-01 |
| Normal-vs-Stage2 |
2.039900E-02 |
| Normal-vs-Stage3 |
3.224800E-01 |
| Normal-vs-Stage4 |
3.144800E-01 |
| Stage1-vs-Stage2 |
9.124500E-02 |
| Stage1-vs-Stage3 |
8.373200E-01 |
| Stage1-vs-Stage4 |
9.975800E-01 |
| Stage2-vs-Stage3 |
9.512400E-02 |
| Stage2-vs-Stage4 |
1.401430E-01 |
| Stage3-vs-Stage4 |
8.874600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.747800E-02 |
| Normal-vs-AfricanAmerican |
7.856600E-01 |
| Normal-vs-Asian |
1.695910E-02 |
| Caucasian-vs-AfricanAmerican |
5.417200E-01 |
| Caucasian-vs-Asian |
1.606950E-01 |
| AfricanAmerican-vs-Asian |
1.494390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.878200E-02 |
| Normal-vs-Female |
8.801700E-02 |
| Male-vs-Female |
5.139400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.630600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.514500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.887700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.460820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.334000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.740400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.816600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.925200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.152400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.146800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.352500E-04 |
| Classical-VS-Follicular |
9.178800E-01 |
| Classical-VS-Other |
5.526000E-01 |
| Classical-VS-Normal |
1.079880E-02 |
| Tall-VS-Follicular |
1.165940E-02 |
| Tall-VS-Other |
3.341400E-01 |
| Tall-VS-Normal |
1.385830E-01 |
| Follicular-VS-Other |
6.939400E-01 |
| Follicular-VS-Normal |
1.255960E-01 |
| Other-VS-Normal |
8.025400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.768050E-02 |
| Normal-vs-N1 |
9.817400E-01 |
| N0-vs-N1 |
1.003840E-01 |
|
|
